GlassScriptPhysician profile
Roxana Cueva Manuel
NPI 1760718233
$2,029.08
in general payments reported to CMS, 2019-2025
13 companies · $95.33 in 2025
The $95.33 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $36.88 · 2022: $269 · 2023: $967 · 2024: $661 · 2025: $95.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,722.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $1,412.53 | 2022-2025 | Prolate, Nalocet, Tanlor |
| Pfizer INC. | $159.57 | 2023-2024 | |
| Abbott Laboratories | $117.19 | 2022 | |
| Abbvie INC. | $105.67 | 2023-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $53.62 | 2022 | |
| Vertos Medical, INC. | $33.32 | 2022 | |
| Valinor Pharma, LLC | $30.90 | 2024 | Movantik |
| Glaxosmithkline, LLC. | $29.66 | 2024 | Bexsero |
| Medtronic, INC. | $24.95 | 2021 | |
| Curonix LLC | $22.88 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Allergan, INC. | $16.18 | 2022 | |
| Collegium Pharmaceutical, INC. | $11.93 | 2021 | |
| Stimwave Technologies Incorporated | $10.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roxana Manuel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.